MM_EYECARE_HOLDINGS_LIMIT - Accounts


Company Registration No. 12887612 (England and Wales)
MM EYECARE HOLDINGS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022
PAGES FOR FILING WITH REGISTRAR
ERROR: Image filename specified not found
MM Eyecare Holdings Limited
MM EYECARE HOLDINGS LIMITED
Company information
Director
Dr N I Mittal
Company number
12887612
Registered office
18 Carey Close
Swindon
England
SN5 6BJ
Accountants
DJH Mitten Clarke
Chester House
Lloyd Drive
Cheshire Oaks Business Park
Ellesmere Port
Cheshire
CH65 9HQ
MM Eyecare Holdings Limited
MM EYECARE HOLDINGS LIMITED
Contents
Page
Accountants' report
1
Balance sheet
2
Statement of changes in equity
3
Notes to the financial statements
4 - 6
MM Eyecare Holdings Limited
MM EYECARE HOLDINGS LIMITED
Chartered Accountants' report to the director on the preparation of the unaudited statutory financial statements of MM Eyecare Holdings Limited for the year ended 30 September 2022
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MM Eyecare Holdings Limited for the year ended 30 September 2022 which comprise, the balance sheet, the statement of changes in equity and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation

This report is made solely to the Board of Directors of MM Eyecare Holdings Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of MM Eyecare Holdings Limited and state those matters that we have agreed to state to the Board of Directors of MM Eyecare Holdings Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than MM Eyecare Holdings Limited and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that MM Eyecare Holdings Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of MM Eyecare Holdings Limited. You consider that MM Eyecare Holdings Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of MM Eyecare Holdings Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

DJH Mitten Clarke
Chester House
Lloyd Drive
Cheshire Oaks Business Park
Ellesmere Port
Cheshire
CH65 9HQ
13 April 2023
MM Eyecare Holdings Limited
MM EYECARE HOLDINGS LIMITED
Balance sheet
as at 30 September 2022
- 2 -
2022
2021
Notes
£
£
£
£
Fixed assets
Investments
4
243,289
243,289
Current assets
Cash at bank and in hand
3,229
5,000
Creditors: amounts falling due within one year
5
(245,027)
(249,915)
Net current liabilities
(241,798)
(244,915)
Net assets/(liabilities)
1,491
(1,626)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
1,391
(1,726)
Total equity
1,491
(1,626)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 13 April 2023
Dr N I Mittal
Director
Company Registration No. 12887612
MM EYECARE HOLDINGS LIMITED
Statement of changes in equity
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 17 September 2020
-
0
-
0
-
Period ended 30 September 2021:
Loss and total comprehensive income for the period
-
(1,726)
(1,726)
Issue of share capital
100
-
100
Balance at 30 September 2021
100
(1,726)
(1,626)
Year ended 30 September 2022:
Profit and total comprehensive income for the year
-
3,117
3,117
Balance at 30 September 2022
100
1,391
1,491
MM EYECARE HOLDINGS LIMITED
Notes to the financial statements
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 4 -
1
Accounting policies
Company information

MM Eyecare Holdings Limited is a private company limited by shares incorporated in England and Wales. The registered office is 18 Carey Close, Swindon, England, SN5 6BJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

MM EYECARE HOLDINGS LIMITED
Notes to the financial statements (continued)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
1
Accounting policies
(Continued)
- 5 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs. As all financial assets are classified within one year, they are not amortised but carried at face value.

 

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price. Financial liabilities classified as payable within one year are carried at face value.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and continue to be measured at face value.

 

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
1
1
MM EYECARE HOLDINGS LIMITED
Notes to the financial statements (continued)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 6 -
4
Fixed asset investments
2022
2021
£
£
Shares in group undertakings and participating interests
243,289
243,289
5
Creditors: amounts falling due within one year
2022
2021
£
£
Other creditors
245,027
249,915
6
Related party transactions

At the balance sheet date the company owes Brignall Opticians Ltd, a subsidiary of MM Eyecare Holdings Limited £9,113 (2021 £9,113).

7
Directors' transactions

At the balance sheet date the company owes the director £235,080 (2021 £239,080). The balance is interest free and repayable on demand.

2022-09-302021-10-01false13 April 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityDr N I Mittal128876122021-10-012022-09-3012887612bus:Director12021-10-012022-09-3012887612bus:RegisteredOffice2021-10-012022-09-30128876122022-09-30128876122021-09-3012887612core:CurrentFinancialInstrumentscore:WithinOneYear2022-09-3012887612core:CurrentFinancialInstrumentscore:WithinOneYear2021-09-3012887612core:ShareCapital2022-09-3012887612core:ShareCapital2021-09-3012887612core:RetainedEarningsAccumulatedLosses2022-09-3012887612core:RetainedEarningsAccumulatedLosses2021-09-3012887612core:ShareCapital2020-09-1612887612core:RetainedEarningsAccumulatedLosses2020-09-1612887612core:RetainedEarningsAccumulatedLosses2020-09-172021-09-30128876122020-09-172021-09-3012887612core:RetainedEarningsAccumulatedLosses2021-10-012022-09-3012887612core:ShareCapital2020-09-172021-09-3012887612core:CurrentFinancialInstruments2022-09-3012887612core:CurrentFinancialInstruments2021-09-3012887612bus:PrivateLimitedCompanyLtd2021-10-012022-09-3012887612bus:SmallCompaniesRegimeForAccounts2021-10-012022-09-3012887612bus:FRS1022021-10-012022-09-3012887612bus:AuditExemptWithAccountantsReport2021-10-012022-09-3012887612bus:FullAccounts2021-10-012022-09-30xbrli:purexbrli:sharesiso4217:GBP